PCR
Simplify VettaFi Private Credit Strategy ETFNYSE
Updated 1 day ago
Coverage building
$17.77-0.67%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -4.3%
- 3 months
- -9.2%
- 1 year
- -24.7%
- 52-week range
- $17.77$24.80
- Dividend, last 12 mo
- $2.29 · 12.89% yield
- Last ex-date
- Sep 25, 2026 · $0.18
- Short interest
- 1.3K sharessettled Sep 30, 2026 · +7.8% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if PCR is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Institutional coverage is still building for this ticker.
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
4 filers reported a long position in PCR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Brookwood Investment Group LLC | $1.3M | 68.7K | -9.1% |
| JANE STREET GROUP, LLC | $233.6K | 12K | New |
| Realta Investment Advisors | $21.1K | 1.1K | Unchanged |
| UBS Group AG | $176 | 9 | New |
Get the Full Analysis for PCR
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.